Authors


Martin Edelman, MD

Latest:

Lingering Unknowns Amid Lung Cancer Breakthroughs: Martin Edelman, MD

Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' abilities to anticipate patients' treatment responses.


Prasaad Ayyanar, MS

Latest:

Understanding the Complexities of Equity Within the Emergence and Utilization of AI in Academic Medical Centers

This editorial discusses positions for academic medical centers to consider when designing and implementing artificial intelligence (AI) tools.


Dawn Lobick, MSN, RN

Latest:

Appropriate ED Utilization Leading to Better Care Coordination

Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.


D. Campbell Liles, MD

Latest:

Operating Room Efficiency of Orthopedic Surgery During the COVID-19 Era

The authors analyzed the impacts of COVID-19 on orthopedic operating room efficiency via comparison of 14,856 surgeries performed before, during, and after the pandemic.


Lindsey A. Herrel, MD, MS

Latest:

Medicare Accountable Care Organizations Reduce Spending on Surgery

Medicare Shared Savings Program accountable care organizations spent less on surgical care by reducing inpatient surgery, increasing outpatient surgery, and reducing spending on postacute care after inpatient surgery.


Jennifer Payton, MHCA, BSN, RN, CNN

Latest:

Medicare Payment Rule Threatens Access to Life-Sustaining Kidney Care

The authors call on Congress to reform Medicare reimbursement for dialysis, saying the recent rule puts clinics at risk of closure.


Vedat Verter, PhD

Latest:

Impact of Psychiatric Follow-Up Frequency on Outcomes and Waiting Times

Naturally occurring variations in appointment frequencies do not appear to have a major impact on clinical outcomes, but they significantly affect waiting times.


April W. Armstrong, MD, MPH

Latest:

Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review

This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.


Avni Kothari, MS

Latest:

Reducing Readmissions in the Safety Net Through AI and Automation

Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while improving clinical and equity outcomes.


Polly McCracken, MA

Latest:

A Scoping Review of US Insurers’ Use of Patient-Reported Outcomes

This scoping review found 350 articles that discuss US health insurance providers’ use of patient-reported outcomes about health-related quality of life.


Anurag Pant, MA

Latest:

Association of Opioid Utilization Management With Prescribing and Overdose

Opioid utilization management in Medicare was associated with mixed effects on opioid prescribing, and prior authorization was associated with a decreased likelihood of subsequent overdose.


David Hutton

Latest:

Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101

Atsena Therapeutics and Nippon Shinyaku have formed an exclusive licensing agreement for ATSN-101, a gene therapy for Leber congenital amaurosis (LCA1). Nippon Shinyaku will commercialize ATSN-101 in the US and Japan, while Atsena retains global rights outside these territories.


Andrew Kuykendall, MD  | Image Credit: © Moffitt Cancer Center
Andrew Kuykendall, MD

Latest:

Fatigue, Quality of Life Improve With Rusfertide: Andrew Kuykendall, MD

Andrew Kuykendall, MD, is an investigator on the phase 3 VERIFY trial (NCT05210790), findings from which demonstrate the safety, reliability, and effectiveness of rusfertide to treat polycythemia vera.


Jaehong Kim, PhD

Latest:

Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments

Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost.


Eboni G. Price-Haywood, MD, MPH

Latest:

Non–Face-to-Face Care Management and Service Utilization in Patients With Diabetes

CMS began reimbursement for non–face-to-face chronic care management in 2015, and results from Louisiana show that it increases outpatient visits but decreases inpatient and emergency department encounters.


Andrey Ostrovsky, MD

Latest:

Contributor: Leveraging Telehealth to Improve Access to Care for Maternal Health

This article explores the challenges and highlights actionable telehealth solutions that enhance access to care, particularly for mothers at higher risk of postpartum depression.


Aaron Yao, PhD

Latest:

Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients

Patients with congestive heart failure and/or chronic obstructive pulmonary disease who had more quarterly primary care visits had lower rates of hospitalizations during the COVID-19 pandemic.


Natalie Bedford

Latest:

Specialty Pharmacy Trends and Technology at Asembia AXS25

Joe DePinto, MBA, of McKesson; Kathi Henson, MBA, of Orsini; and Natalie Bedford of McKesson discuss how Asembia's AXS25 Specialty Summit fosters collaboration among industry leaders, exploring technology trends to enhance specialty pharmacy and patient care delivery.


Claudia Nau, PhD

Latest:

Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index

The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.


Megan J. Shen, PhD

Latest:

Building Research Capacity in Primary Care Practices That Serve Predominantly Racial and Ethnic Minority Populations

The successful collaboration between a primary care–based network of practices and academic researchers demonstrates feasibility and the need for more funding for primary care research.


Ron Southwick

Latest:

After Tornado Damages Pfizer Plant, Hospitals Brace for Shortages

Analysts warned of the potential for some shortages until the company can move production elsewhere. The North Carolina plant produces a quarter of the company’s sterile injectables used in hospitals.


Kristy Helscel, MPH

Latest:

Improving Care Coordination and Reducing ED Utilization Through Patient Navigation

A navigation program demonstrated decreased odds of repeat emergency department (ED) visits in patients with low baseline ED utilization and increased odds of follow-up primary care appointments.


Run Wang, MB

Latest:

How Do Primary Hospitals Enact Early Response to the Relaxation of COVID-19 Prevention and Control Measures? The Experience From Chengdu, China

This article examines how primary hospitals in Chengdu, China, responded to the relaxation of COVID-19 prevention and control measures in December 2022.


Tham Thi Le, PhD, MPH

Latest:

Patterns of Opioid Use in Commercially Insured Patients With Cancer

Among the fewer than half of patients with cancer who received opioid fills, a relatively small proportion (2.5%) had potentially problematic opioid use.


Preeti N. Malani, MD, MSJ

Latest:

Older Adults’ Perspectives on Emergency Department Costs During COVID-19

Most older US adults have concerns about emergency department visit affordability. Lower income, being uninsured, poor or fair physical/mental health, and younger age were associated with increased concerns.


Joneigh Khaldun, MD, MPH, FACEP

Latest:

Building Community-Level Solutions to Address Health Disparities: A Q&A With Dr Joneigh Khaldun

Joneigh Khaldun, MD, MPH, FACEP, vice president and chief health equity officer for CVS Health, speaks on the launch of her organization’s Community Equity Alliance that aims to address structural barriers to equitable care in underserved communities through partnerships with local academic and health care institutions.


Amnuay Kleebayoon, PhD

Latest:

Comment on COVID-19 Vaccine Hesitancy and Health Literacy

This letter discusses COVID-19 vaccine hesitancy and health literacy.


Marianna M. Sockrider, MD, DrPH

Latest:

Evaluation of a Pediatric Asthma High-risk Scoring Algorithm

An asthma risk score using 7 clinically relevant parameters evaluated in a pediatric Medicaid managed care population can stratify risk for following-year asthma hospitalization.


Benjamin Howell, PhD, MPP

Latest:

Implementing Multistate Behavioral Health Pay-for-Performance Initiatives in Medicaid Managed Care

The authors describe a pay-for-performance initiative targeting behavioral health providers, which was introduced by a large Medicaid managed care organization across multiple states.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo